M&A - ULTRALIFE CORP

Form Type: NT 10-K

Filing Date: 2025-03-07

Corporate Action: Acquisition

Type: New

Accession Number: 000143774925006653

Filing Summary: Ultralife Corporation filed Form NT 10-K on March 7, 2025, notifying about a late filing of their annual report for the period ended December 31, 2024. The delay stems from the acquisition of Electrochem Solutions, Inc. completed on October 31, 2024, where Ultralife acquired all outstanding shares from Integer Holdings Corporation. The company faced challenges obtaining financial results from Electrochem’s former parent company, which is necessary for preparing compliant consolidated financial statements and completing the required audit. Ultralife expects to file the 10-K within the timeframe allowed by Rule 12b-25 by April 1, 2025. Additionally, the notification indicates that all other periodic reports have been filed and anticipates no significant changes in results of operations for the reporting period compared to the previous fiscal year.

Document Link: View Document

Form Type: 8-K/A

Filing Date: 2025-01-16

Corporate Action: Acquisition

Type: Update

Accession Number: 000143774925001267

Filing Summary: This document amends the Current Report on Form 8-K filed on November 6, 2024, which reported Ultralife Corporation's acquisition of Electrochem Solutions, Inc. on October 31, 2024. The amendment is intended to include the audited historical financial statements of Electrochem as well as unaudited pro forma financial information, which were not included in the original filing. The filed documents include audited combined financial statements for the year ended December 31, 2023 and unaudited combined financial statements for the nine months ended September 27, 2024. Additionally, it presents unaudited pro forma combined financial information as of September 30, 2024, addressing both the nine-month period and the year ended December 31, 2023. No other changes have been made to the Original Form 8-K.

Document Link: View Document